116 related articles for article (PubMed ID: 1829929)
1. Development of breast cancer during long-term tamoxifen therapy for lymphangioleiomyomatosis.
Millward MJ; Cantwell BM
Eur J Cancer; 1991; 27(6):806. PubMed ID: 1829929
[No Abstract] [Full Text] [Related]
2. Tamoxifen for lymphangioleiomyomatosis.
Tomasian A; Greenberg MS; Rumerman H
N Engl J Med; 1982 Mar; 306(12):745-6. PubMed ID: 7062945
[No Abstract] [Full Text] [Related]
3. Lymphangioleiomyomatosis: treatment with hormonal manipulation.
Brock ET; Votto JJ
N Y State J Med; 1986 Oct; 86(10):533-6. PubMed ID: 3466061
[No Abstract] [Full Text] [Related]
4. [Case report on the hormonal aspects of the therapy of pulmonary lymphangioleiomyomatosis].
Bettendorf U; Bauer KH; Kaiser E
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():1024-5. PubMed ID: 6647245
[No Abstract] [Full Text] [Related]
5. [2 cases of lymphangioleiomyomatosis treated by hormonal manipulation].
Anker N; Francis D; Viskum K
Ugeskr Laeger; 1993 Jul; 155(30):2354-6. PubMed ID: 8346582
[TBL] [Abstract][Full Text] [Related]
6. [A case of pulmonary lymphangiomyomatosis with tuberous sclerosis--treated with tamoxifen].
Hara H; Tono Y; Matsushima T; Manabe T
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Aug; 25(8):918-23. PubMed ID: 3694971
[No Abstract] [Full Text] [Related]
7. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens.
Shen A; Iseman MD; Waldron JA; King TE
Chest; 1987 May; 91(5):782-5. PubMed ID: 3032524
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary lymphangiomyomatosis associated with tuberous sclerosis. Treatment with tamoxifen and tetracycline-pleurodesis.
Luna CM; Gené R; Jolly EC; Nahmod N; Defranchi HA; Patiño G; Elsner B
Chest; 1985 Sep; 88(3):473-5. PubMed ID: 4028861
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiomyomatosis: a report of three cases treated with tamoxifen.
Clemm C; Jehn U; Wolf-Hornung B; Siemon G; Walter G
Klin Wochenschr; 1987 Apr; 65(8):391-3. PubMed ID: 3586575
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary lymphangiomyomatosis.
Eisera NB; Venegoni E; Colombi R
J R Soc Med; 1988 Oct; 81(10):607-9. PubMed ID: 3184096
[No Abstract] [Full Text] [Related]
11. Highly effective sirolimus therapy for abdominal lymphangioleiomyoma.
Lecuelle D; Basille D; Renard C; Saint F; Jounieaux V
Respir Med Res; 2019 May; 75():32-34. PubMed ID: 31262426
[No Abstract] [Full Text] [Related]
12. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy.
Sawicka EH; Morris AJ
Br J Dis Chest; 1985 Oct; 79(4):400-6. PubMed ID: 2932139
[TBL] [Abstract][Full Text] [Related]
13. Lymphangioleiomyomatosis--treatment with progesterone.
Poh SC; Wang YT
Singapore Med J; 1991 Aug; 32(4):258-61. PubMed ID: 1776007
[TBL] [Abstract][Full Text] [Related]
14. What׳s the role of sirolimus on the treatment of lymphangioleiomyomatosis (LAM)?: Merely tuning up of LAM-associated dysfunctional lymphatic vessels rather than cytoreduction?
Suina K; Hayashi T; Mitani K; Suzuki K; Takahashi K; Seyama K
Respir Investig; 2014 Jul; 52(4):274-6. PubMed ID: 24998376
[No Abstract] [Full Text] [Related]
15. Lymphangioleiomyomatosis. Clinical course in 32 patients.
Taylor JR; Ryu J; Colby TV; Raffin TA
N Engl J Med; 1990 Nov; 323(18):1254-60. PubMed ID: 2215609
[No Abstract] [Full Text] [Related]
16. [Differential diagnosis of spontaneous pneumothorax--pulmonary lymphangioleiomyomatosis. Clinical aspects, diagnosis and therapy].
Schönemann B; Merkle P
Chirurg; 1990 Apr; 61(4):301-3. PubMed ID: 2140768
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary lymphangiomyomatosis. Long-term survival in a patient with poor response to medroxyprogesterone.
Bevelaqua FA; Epstein H
Chest; 1985 Apr; 87(4):552-3. PubMed ID: 3979149
[No Abstract] [Full Text] [Related]
18. Variability in the prevalence of acute bronchoresponsiveness in different populations of patients with lymphangioleiomyomatosis.
Burger CD
Chest; 2008 Jul; 134(1):217; author reply 218. PubMed ID: 18628234
[No Abstract] [Full Text] [Related]
19. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.
Rossi GA; Balbi B; Oddera S; Lantero S; Ravazzoni C
Am Rev Respir Dis; 1991 Jan; 143(1):174-6. PubMed ID: 1824744
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen-induced tumor stimulation and withdrawal response.
Legault-Poisson S; Jolivet J; Poisson R; Beretta-Piccoli M; Band PR
Cancer Treat Rep; 1979; 63(11-12):1839-41. PubMed ID: 230894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
